Product Information
LAMOTRIGINE 5 MG DISPER TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1673 per EA under NDC 68462022801. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Feb 19, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462022801
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA079099FDA Approved
2/19/2009
TE Code
AB
On Market Since
2/19/2009
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE 5 MG DISPER TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 37.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1673 per EA |
|---|---|
| All-time high | $0.3251 (Jan 13, 2021) |
| All-time low | $0.1144 (Feb 20, 2019) |
| 52-week high | $0.1681 |
| 52-week low | $0.1464 |
| Median price | $0.2039 |
| Average price | $0.2131 |
| Largest weekly change | +52.2% (Aug 17, 2016) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE 5 MG DISPER TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE 5 MG DISPER TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1673 per EA (NDC 68462022801), effective Sep 30, 2026.
How has the price of LAMOTRIGINE 5 MG DISPER TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE 5 MG DISPER TABLET has declined 37.2%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE 5 MG DISPER TABLET?
Since Nov 28, 2013, the NADAC for LAMOTRIGINE 5 MG DISPER TABLET has ranged from a low of $0.1144 (Feb 20, 2019) to a high of $0.3251 (Jan 13, 2021), with a median of $0.2039 per EA.
Are there cheaper alternatives to LAMOTRIGINE 5 MG DISPER TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 5 MG DISPER TABLET, is $0.1201 per EA — about 28% below LAMOTRIGINE 5 MG DISPER TABLET.
Who manufactures LAMOTRIGINE 5 MG DISPER TABLET?
LAMOTRIGINE 5 MG DISPER TABLET (NDC 68462022801) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.